Navigation Links
Ranbaxy in Fray to Buy Merck's Generic Drugs Unit

Davos: After six global acquisitions last year, India's Ranbaxy Laboratories has entered the market again to acquire the generic drugs business of German// pharmaceuticals major Merck in a deal estimated at over $5 billion.

‘We are in talks with private equity funds to finance the deal,’ Ranbaxy's chief executive Malvinder Singh said on the margins of the annual meeting of the World Economic Forum (WEF) here. ‘We are being hounded by them for the takeover.’

According to Singh, the due diligence for the acquisition was expected to start next month. He, however, declined to give any financial details.

‘Merck makes sense for us since it would result in a major gain for us in the global generics business and a strategic fit for our activities,’ Singh said, adding: ‘I have been talking to some private equity funds even here.’

According to pharmaceutical industry sources, Merck's generics business records annual revenues around $2.5 billion and has the potential to more than triple Ranbaxy's turnover to around $3.75 billion after the acquisition.

The merger of Ranbaxy and Merck's generics business could result in a stable of 100 products in the US alone for drugs in diabetics, neurology, cardiovascular and neurology, among other areas.

The generics unit of the German major is the largest supplier in markets like Australia, France and Scandinavia.

Ranbaxy had acquired four companies in Europe last year, including Terapia of Romania, for $324-million. The company has approval from shareholders to sell bonds and shares worth $1.5 billion.


Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Post Your Comments:

(Date:12/1/2015)... ... 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, 2015) ... has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) service ... special needs providers that excel in synthesizing the areas of clinical quality, staff ...
(Date:12/1/2015)... ... 2015 , ... PYA’s latest white paper, “ PYA Leadership ... “pain point” for merging or aligning healthcare provider organizations—when mergers and other affiliation ... This quick-read guidance suggests that failing to recognize the power of an effective ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. ... a Modern Man for 2015. , Angeleno Magazine is a division of ... Established in 1994, Modern Luxury includes more than 50 magazine titles across 15 ...
(Date:11/30/2015)... ... 2015 , ... Trevor and Taylor Crabb have unveiled an exciting new ... represent the United States. This hybrid crowdfunding campaign is designed to provide ... in addition to offering corporate sponsors with some great marketing deliverables with the brothers ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... programs of the19th Bi-National Convention of the Federation of Philippine American Chambers of ... in Las Vegas, Nevada. , 1Heart Caregiver Services, as an active delegate ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... UPPSALA, Sweden , December 1, 2015 /PRNewswire/ ... the International Breast Cancer Study Group (IBCSG, Bern ... Brussels ) to be part of a state of ... new cancer drug.  --> --> ... breast cancer being treated with anti-hormonal therapy in combination with ...
(Date:12/1/2015)... December 1, 2015 Biovicas ... Study Group (IBCSG, Bern ) ... i en klinisk studie av palbociclib, ett nytt ... --> Studien, med namn PYTHIA, kommer följa ... läkemedel i kombination med palbociclib, som tillhör klassen ...
(Date:11/30/2015)... , Dec. 1, 2015 Researchers have ... measures body part thickness and checks for motion, positioning ... a feasibility study presented today at the annual meeting ... (RSNA). Steven Don , M.D., ... Washington University School of Medicine in St. ...
Breaking Medicine Technology: